With Komodo:
- 
Get high-fidelity R&E insights for 265 million unique individuals at the patient level aligned with the 2020 U.S. Census at the state level
- 
Model inclusion/exclusion criteria to determine its impact on recruitment diversity, and adjust without impacting clinical endpoints
- 
Boost patient pool diversity by 50% with unprecedented views of HCP patient-level demographics
- 
Intervene at key points in the patient journey specific to racial and ethnic groups
- 
Choose trial sites that will facilitate patient recruitment within underserved and underrepresented populations
              
                
                WANT TO LEARN MORE?
                
                
              
              
              
          
                
                  BE DATA SAVVY
                  
                
              
              
            BE DATA SAVVY
BE DATA SAVVY
            Nearly one-third (32%) of Clinical Development teams report they do not yet use solutions enhanced with AI, which is essential for the timely identification of patients who are screening-eligible for clinical trials.
 
          .png)